跳至主要内容
临床试验/IRCT2015071017413N12
IRCT2015071017413N12已完成未知

Comparison of efficacy and safety of two natural surfactants, Curosurf and Survanta in treatment of respiratory distress syndrome: A randomized clinical trial

Baqiyatallah University of Medical Sciences, Deputy of Research0 个研究点目标入组 112 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 1 day(—)
性别
All

入选标准

  • Neonates were born with RDS diagnosis in Najmieh and Baqiyatallah hospitals; weight of 750 to 1750 gr; gestational age less than 35 weeks; O2 saturation 85% to 96%; signed informed consent by parents; and age = 6 hours at the time of randomization. Exclusion criteria: Congenital heart diseases and other life threatening congenital anomalies; respiratory failure due to other causes, 5 minute Apgar score = 3; proven fetal lung maturity profile from amniocentesis; prior treatment with exogenous surfactant; prolonged (= 3 weeks) rupture of membranes; untreated hypotension or hypoglycemia; use of high-frequency ventilation prior to first dose of surfactant; and severe grades of intra-ventricular hemorrhage (grades III or IV) prior to surfactant.

排除标准

  • 未提供

研究者

发起方
Baqiyatallah University of Medical Sciences, Deputy of Research

相似试验

Comparison of efficacy and safety of two natural... | 临床试验